CoChat

Melanoma cell adhesion molecule–positive CD 8Tlymphocytes mediate central nervous system inflammation

Larochelle, Catherine, Lécuyer, Marc‐André, Alvarez, Jorge Ivan, Charabati, Marc, Saint‐Laurent, Olivia, Ghannam, Soufiane, Kebir, Hania, Flanagan, Ken, Yednock, Ted, Duquette, Pierre, Arbour, Nathalie, Prat, Alexandre · 2015 · Annals of Neurology
Cited by 73

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Objective: Although Tc17 lymphocytes are enriched in the central nervous system (CNS) of multiple sclerosis (MS) subjects and of experimental autoimmune encephalomyelitis (EAE) animals, limited information is available about their recruitment into the CNS and their role in neuroinflammation. Identification of adhesion molecules used by autoaggressive CD8+T lymphocytes to enter the CNS would allow further characterization of this pathogenic subset and could provide new therapeutic targets in MS. We propose that melanoma cell adhesion molecule (MCAM) is a surface marker and adhesion molecule used by pathogenic CD8+T lymphocytes to access the CNS. Methods: Frequency, phenotype, and function of MCAM+CD8+T lymphocytes was characterized using a combination of ex vivo, in vitro, in situ, and in vivo approaches in humans and mice, including healthy controls, MS subjects, and EAE animals. Results: Herein, we report that MCAM is expressed by human effector CD8+T lymphocytes and it is strikingly upregulated during MS relapses. We further demonstrate that MCAM+CD8+T lymphocytes express more interleukin 17, interferon γ, granulocyte‐macrophage colony–stimulating factor, and tumor necrosis factor than MCAM−lymphocytes, and exhibit an enhanced killing capacity toward oligodendrocytes. MCAM blockade restricts the transmigration of CD8+T lymphocytes across human blood–brain barrier endothelial cells in vitro, and blocking or depleting MCAM in vivo reduces chronic neurological deficits in active, transfer, and spontaneous progressive EAE models. Interpretation: Our data demonstrate that MCAM identifies encephalitogenic CD8+T lymphocytes, suggesting that MCAM could represent a biomarker of MS disease activity and a valid target for the treatment of neuroinflammatory conditions. Ann Neurol 2015;78:39–53

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24415

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 73

Metadata

Authors
Larochelle, C., Lécuyer, M., Alvarez, J. I., Charabati, M., Saint‐Laurent, O., Ghannam, S., Kebir, H., Flanagan, K., Yednock, T., Duquette, P., Arbour, N., & Prat, A.
Venue
Annals of Neurology
Publisher
Wiley
Published
2015-05-20
Volume
78
Issue
1
Pages
39-53
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1525631190
Cited by
73
References
16
FWCI
5.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Melanoma cell adhesion molecule–positive CD 8Tlymphocytes mediate central nervous system inflammation. https://app.cochat.ai/papers/10.1002/ana.24415
The paper
Larochelle, C., Lécuyer, M., Alvarez, J. I., Charabati, M., Saint‐Laurent, O., Ghannam, S., Kebir, H., Flanagan, K., Yednock, T., Duquette, P., Arbour, N., & Prat, A. (2015). Melanoma cell adhesion molecule–positive CD 8Tlymphocytes mediate central nervous system inflammation. Annals of Neurology. https://doi.org/10.1002/ana.24415

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.